Stockreport

How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story [Yahoo! Finance]

Harrow Health, Inc.  (HROW) 
Last harrow health, inc. earnings: 11/13 04:21 pm Check Earnings Report
PDF Harrow, Inc. has secured a key win as CVS's pharmacy benefit manager replaced Xiidra with Harrow's dry eye drug Vevye on its Tier 1 formulary, and the company recently p [Read more]